{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:09:04Z","timestamp":1793725744265,"version":"4.6.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Changzhou Municipal Science and Technology Bureau Basic Research project","award":["CJ20220212"],"award-info":[{"award-number":["CJ20220212"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43719-x","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T22:44:35Z","timestamp":1773441875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exosome-mediated delivery of miRNA-1290 inhibitor enhances JNK-dependent tissue-resident memory T cell immunity in prostate cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Bin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songnian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"43719_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"43719_CR2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","volume":"398","author":"S Sandhu","year":"2021","unstructured":"Sandhu, S. et al. Prostate cancer. Lancet 398, 1075\u20131090. https:\/\/doi.org\/10.1016\/S0140-6736(21)00950-8 (2021).","journal-title":"Lancet"},{"key":"43719_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","volume":"70","author":"MY Teo","year":"2019","unstructured":"Teo, M. Y., Rathkopf, D. E. & Kantoff, P. Treatment of Advanced Prostate Cancer. Annu. Rev. Med. 70, 479\u2013499. https:\/\/doi.org\/10.1146\/annurev-med-051517-011947 (2019).","journal-title":"Annu. Rev. Med."},{"key":"43719_CR4","doi-asserted-by":"publisher","first-page":"8079","DOI":"10.2147\/OTT.S248925","volume":"13","author":"Y Tan","year":"2020","unstructured":"Tan, Y. et al. miR-148a Regulates the Stem Cell-Like Side Populations Distribution by Affecting the Expression of ACVR1 in Esophageal Squamous Cell Carcinoma. Onco Targets Ther. 13, 8079\u20138094. https:\/\/doi.org\/10.2147\/OTT.S248925 (2020).","journal-title":"Onco Targets Ther."},{"key":"43719_CR5","doi-asserted-by":"publisher","unstructured":"Coradduzza, D. et al. Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms23031626 (2022).","DOI":"10.3390\/ijms23031626"},{"key":"43719_CR6","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/annonc\/mdw279","volume":"27","author":"H Imaoka","year":"2016","unstructured":"Imaoka, H. et al. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. Ann. Oncol. 27, 1879\u20131886. https:\/\/doi.org\/10.1093\/annonc\/mdw279 (2016).","journal-title":"Ann. Oncol."},{"key":"43719_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1159\/000495328","volume":"51","author":"N Ta","year":"2018","unstructured":"Ta, N. et al. miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1. Cell. Physiol. Biochem. 51, 711\u2013728. https:\/\/doi.org\/10.1159\/000495328 (2018).","journal-title":"Cell. Physiol. Biochem."},{"key":"43719_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1039\/c9nr09011h","volume":"12","author":"H Nie","year":"2020","unstructured":"Nie, H. et al. Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer. Nanoscale 12, 877\u2013887. https:\/\/doi.org\/10.1039\/c9nr09011h (2020).","journal-title":"Nanoscale"},{"key":"43719_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-020-01261-y","volume":"19","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. Correction to: CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p. Mol. Cancer. 19, 144. https:\/\/doi.org\/10.1186\/s12943-020-01261-y (2020).","journal-title":"Mol. Cancer"},{"key":"43719_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-019-0959-5","volume":"18","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Mol. Cancer. 18, 40. https:\/\/doi.org\/10.1186\/s12943-019-0959-5 (2019).","journal-title":"Mol. Cancer"},{"key":"43719_CR11","doi-asserted-by":"publisher","first-page":"111648","DOI":"10.1016\/j.biopha.2021.111648","volume":"139","author":"JY Lin","year":"2021","unstructured":"Lin, J. Y. & Yeh, T. H. Rutaecarpine administration inhibits cancer cell growth in allogenic TRAMP-C1 prostate cancer mice correlating with immune balance in vivo. Biomed. Pharmacother. 139, 111648. https:\/\/doi.org\/10.1016\/j.biopha.2021.111648 (2021).","journal-title":"Biomed. Pharmacother"},{"key":"43719_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/14756366.2016.1252760","volume":"32","author":"S Astigiano","year":"2017","unstructured":"Astigiano, S., Puglisi, A., Mastracci, L., Fais, S. & Barbieri, O. Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice. J. Enzyme Inhib. Med. Chem. 32, 363\u2013368. https:\/\/doi.org\/10.1080\/14756366.2016.1252760 (2017).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"43719_CR13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar, S. et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546, 498\u2013503. https:\/\/doi.org\/10.1038\/nature22341 (2017).","journal-title":"Nature"},{"key":"43719_CR14","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013462. https:\/\/doi.org\/10.1093\/nar\/gkv1070 (2016).","journal-title":"Nucleic Acids Res."},{"key":"43719_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata, H. et al. Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 27, 29\u201334. https:\/\/doi.org\/10.1093\/nar\/27.1.29 (1999).","journal-title":"Nucleic Acids Res."},{"key":"43719_CR16","doi-asserted-by":"publisher","first-page":"e14396","DOI":"10.1111\/and.14396","volume":"54","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Hsa-miR-1290 is associated with stemness and invasiveness in prostate cancer cell lines by targeting RORA. Andrologia 54, e14396. https:\/\/doi.org\/10.1111\/and.14396 (2022).","journal-title":"Andrologia"},{"key":"43719_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41420-022-01163-6","volume":"8","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. Cancer associated fibroblasts secreted exosomal miR-1290 contributes to prostate cancer cell growth and metastasis via targeting GSK3beta. Cell. Death Discov. 8, 371. https:\/\/doi.org\/10.1038\/s41420-022-01163-6 (2022).","journal-title":"Cell. Death Discov"},{"key":"43719_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.eururo.2014.07.035","volume":"67","author":"X Huang","year":"2015","unstructured":"Huang, X. et al. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. Eur. Urol. 67, 33\u201341. https:\/\/doi.org\/10.1016\/j.eururo.2014.07.035 (2015).","journal-title":"Eur. Urol."},{"key":"43719_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-025-2958-3","author":"D Liu","year":"2025","unstructured":"Liu, D. et al. Selective expansion of TCF7-expressing tumor-reactive T cell subpopulations during ovarian tumor-infiltrating T cell production ex vivo. Sci. China Life Sci. https:\/\/doi.org\/10.1007\/s11427-025-2958-3 (2025).","journal-title":"Sci. China Life Sci."},{"key":"43719_CR20","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.4049\/jimmunol.1402711","volume":"194","author":"F Djenidi","year":"2015","unstructured":"Djenidi, F. et al. CD8\u2009+\u2009CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients. J. Immunol. 194, 3475\u20133486. https:\/\/doi.org\/10.4049\/jimmunol.1402711 (2015).","journal-title":"J. Immunol."},{"key":"43719_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JS Arthur","year":"2013","unstructured":"Arthur, J. S. & Ley, S. C. Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 13, 679\u2013692. https:\/\/doi.org\/10.1038\/nri3495 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"43719_CR22","doi-asserted-by":"publisher","first-page":"155889","DOI":"10.1016\/j.prp.2025.155889","volume":"269","author":"CW Peng","year":"2025","unstructured":"Peng, C. W., Ma, P. L., Dai, H. T. & Schizandrin A promotes apoptosis in prostate cancer by inducing ROS-mediated endoplasmic reticulum stress and JNK MAPK signaling activation. Pathol. Res. Pract. 269, 155889. https:\/\/doi.org\/10.1016\/j.prp.2025.155889 (2025).","journal-title":"Pathol. Res. Pract."},{"key":"43719_CR23","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.32604\/or.2024.048007","volume":"32","author":"Y Yin","year":"2024","unstructured":"Yin, Y. et al. Caffeic acid hinders the proliferation and migration through inhibition of IL-6 mediated JAK-STAT-3 signaling axis in human prostate cancer. Oncol. Res. 32, 1881\u20131890. https:\/\/doi.org\/10.32604\/or.2024.048007 (2024).","journal-title":"Oncol. Res."},{"key":"43719_CR24","doi-asserted-by":"publisher","first-page":"xii33","DOI":"10.1093\/annonc\/mdx683","volume":"28","author":"A Marabelle","year":"2017","unstructured":"Marabelle, A., Tselikas, L., de Baere, T. & Houot, R. Intratumoral immunotherapy: using the tumor as the remedy. Ann. Oncol. 28, xii33\u2013xii43. https:\/\/doi.org\/10.1093\/annonc\/mdx683 (2017).","journal-title":"Ann. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43719-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43719-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43719-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T23:19:30Z","timestamp":1777245570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43719-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43719"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43719-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of Changzhou Cancer (Fourth People\u2019s) Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants\u2019 legal guardians\/next of kin.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"13472"}}